Hinge Health Beats Q3 With 52% Revenue Growth, Raises 2026 Guidance; President Moves to Board
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Hinge Health posted 52% revenue growth to $235.0 million, swung to $50.3 million of GAAP operating income and raised full-year guidance to $879-881 million. President James Pursley will resign January 1, 2027 and join the board, with CEO Daniel Perez taking on the President role.
Key Events · Earnings and Guidance · HNGE
-
Q3 Revenue Jumps 52% to $235M
Revenue rose to $235.0 million from $154.2 million a year earlier, with GAAP gross margin at 87% versus 82%.
-
Profit Swing and Strong Cash Generation
GAAP income from operations was $50.3 million (21% margin) versus a $6.1 million loss; free cash flow reached $112.7 million, a 48% margin.
-
Full-Year Guidance Raised
2026 revenue guidance lifted to $879-881 million (50% growth at midpoint) and non-GAAP operating margin midpoint to 30%, about 1,000 bps better than 2025; Q4 revenue guided to $249-251 million.
-
President Moves to Board; CEO Adds Title
James Pursley resigns as President effective January 1, 2027 and becomes a Class II director January 4, 2027; CEO Daniel Perez adds the President title with no added compensation.
Analysis · HNGE · Technology
Revenue of $235.0 million rose 52% year-over-year, and the company swung to $50.3 million of GAAP operating income from a $6.1 million loss, with free cash flow of $112.7 million. Management raised full-year revenue guidance to $879-881 million and lifted the non-GAAP operating margin midpoint to 30%, roughly 1,000 basis points better than 2025. Separately, President James Pursley steps down January 1, 2027 and joins the board January 4, 2027, with CEO Daniel Perez adding the President title — a planned transition, not a disagreement, and it removes a layer of senior management while keeping Pursley as a director and paid advisor under a non-compete.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 50.3% of the 199 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HNGE was trading at $115.60 on NYSE in the Technology sector, with a market capitalization of approximately $9.3B. The 52-week trading range was $30.08 to $118.87. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.